Clinical trial
Phase I Study of Preoperative Therapy Imatinib Mesylate and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor (GIST)
NCT07171203 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Study of Preoperative Therapy Imatinib Mesylate and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor (GIST)
- Lead sponsor
- University of California, San Diego
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- May 13, 2026
- Completion date
- July 31, 2031
- Enrollment
- 18 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.